Association between Machado-Joseph disease and oxidative stress biomarkers

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 757, Issue 2, 2013, Pages 99-103

  Pacheco, Laura Segabinazzi ^a   da Silveira, Aron Ferreira ^a   Trott, Alexis ^b   Houenou, Lucien J ^c   Algarve, Thaís Doeler ^a   Belló, Caroline ^a   Lenz, Adriano Flesch ^a   Mânica Cattani, Maria Fernanda ^a   da Cruz, Ivana Beatrice Mânica ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b UNIVERSIDADE DO OESTE DE SANTA CATARINA   (Brazil)

^c Forsyth Technical Community College   (United States)

Author keywords

Antioxidant enzymes; Genotoxicity; Machado Joseph disease; Oxidative stress; Spinocerebellar ataxia

Indexed keywords

BIOLOGICAL MARKER; CARBONYL DERIVATIVE; CATALASE; DICHLOROFLUORESCEIN; POLYPHENOL DERIVATIVE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOL GROUP;

ADULT; ARTICLE; CLINICAL ARTICLE; COMET ASSAY; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DAMAGE; FEMALE; HUMAN; MACHADO JOSEPH DISEASE; MALE; OXIDATIVE STRESS; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL;

ANTIOXIDANT ENZYMES; GENOTOXICITY; MACHADO-JOSEPH DISEASE; OXIDATIVE STRESS; SPINOCEREBELLAR ATAXIA;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CATALASE; FEMALE; HUMANS; LYMPHOCYTES; MACHADO-JOSEPH DISEASE; MALE; MIDDLE AGED; OXIDATIVE STRESS;

EID: 84885850806     PISSN: 13835718     EISSN: 18793592     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2013.06.023     Document Type: Article

References (33)

1. Matos C.A., de Macedo-Ribeiro S., Carvalho A.L. Polyglutamine diseases: the special case of ataxin-3 and Machado-Joseph disease. Prog. Neurobiol. 2011, 95:26-48.
2. Di Prospero N.A., Fischbeck K.H. Therapeutics development for triplet repeat expansion diseases. Nat. Rev. Genet. 2005, 6:756-765.
3. Costa M.D., Paulson H.L. Toward understanding Machado-Joseph disease. Prog. Neurobiol. 2012, 97:239-257.
4. D'Abreu A., França M.C., Paulson H.L., Lopes-Cendes I. Caring for Machado-Joseph disease: current understanding and how to help patients. Parkinsonism Relat. Disord. 2010, 16:2-7.
5. Trott A., Houenou L.J. Spinocerebellar ataxias: an update of SCA genes. Recent Pat. DNA Gene Seq. 2012, 6:115-121.
6. Beal M.F. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann. Neurol. 1995, 38:357-366.
7. Puranam K.L., Wu G., Strittmatter W.J. Polyglutamine expansion inhibits respiration by increasing reactive oxygen species in isolated mitochondria. Biochem. Biophys. Res. Commun. 2006, 341:607-613.
8. Nakamura T., Lipton S.A. Redox modulation by S-nitrosylation contributes to protein misfolding, mitochondrial dynamics, and neuronal synaptic damage in neurodegenerative diseases. Cell Death Differ. 2011, 18:1478-1486.
9. Araujo J., Breuer P., Dieringer S., Krauss S., Dorn S., Zimmermann K., Pfeifer A., Klockgether T., Wuellner U., Evert B.O. FOXO4-dependent upregulation of superoxide dismutase-2 in response to oxidative stress is impaired in spinocerebellar ataxia type 3. Hum. Mol. Genet. 2011, 20:2928-2941.
10. Chou A.H., Yeh T.H., Kuo Y.L., Kao Y.C., Jou M.J., Hsu C.Y., Tsai S.R., Kakizuka A., Wang H.L. Polyglutamine-expanded ataxin-3 activates mitochondrial apoptotic pathway by upregulating Bax and downregulating Bd-xl. Neurobiol. Dis. 2006, 21:333-345.
11. Wong S.L., Chan W.M., Chan H.Y. Sodium dodecyl sulfate-insoluble oligomers are involved in polyglutamine degeneration. FASEB J. 2008, 22:3348-3357.
12. Yu Y.C., Kuo C.L., Cheng W.L., Liu C.S., Hsieh M. Decreased antioxidant enzyme activity an increased mitochondrial DNA damage in cellular models of Machado-Joseph disease. J. Neurosci. Res. 2009, 87:1884-1891.
13. Laço M.N., Oliveira C.R., Paulson H.L., Rego A.C. Compromised mitochondrial complex II in models of Machado-Joseph disease. Biochim. Biophys. Acta 2012, 1822:139-149.
14. Berg K., Wood-Dauphinee S.L., Williams J., Gayton D. Measuring balance in the elderly: preliminary development of an instrument. Physiother. Canada 1989, 41:304-308.
15. Castagno L.A. A new method for sensory organization tests: the foam-laser dynamic posturography. Rev. Bras. Otorrinolaringol. 1994, 60:287-296.
16. Bachorik P.S., Albers J.J. Precipitation methods for quantification of lipoproteins. Methods Enzymol. 1986, 129:78-100.
17. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972, 18:499-502.
18. Jentzsch A.M., Bachmann H., Fürst P., Biesalski H.K. Improved analysis ofmalondialdehyde in human body fluids. Free Radic. Biol. Med. 1996, 20:251-256.
19. Levini R.L., Garland D., Oliver C.N., Amici A., Climent I., Lenz A.G. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990, 186:464-468.
20. Aebi H. Catalase in vitro. Methods Enzymol. 1984, 105:121-126.
21. McCord J.M., Fridovich I. Superoxide dismutase: an enzymatic function for erythrocuprein (hemocuprein). J. Biol. Chem. 1969, 244:6049-6055.
22. Ellman G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959, 82:70-77.
23. Chandra S., de Mejia E.G. Polyphenolic compounds, antioxidant capacity, and quinine reductase activity of an aqueous extract of Ardisia compressa in comparison to mate (Ilex paraguariensis) and green (Camellia sinensis) teas. J. Agric. Food Chem. 2004, 52:3583-3589.
24. Wallace D.R., Dodson S.L., Nath A., Booze R.M. Delta opioid agonists attenuate TAT(1-72)-induced oxidative stress in SK-N-SH cells. Neurotoxicology 2006, 27:101-106.
25. Singh N., McCoy M., Tice R.R., Schneider E.L. A simple technique for quantification of low levels of DNA damage in individuals cells. Exp. Cell Res. 1995, 175:184-191.
26. Dickinson D.A., Forman H.J. Cellular glutathione and thiols metabolism. Biochem. Pharmacol. 2002, 64:1019-1026.
27. Pitts A., Dailey K., Newington J.T., Chien A., Arseneault R., Cann T., Thompson L.M., Cumming R.C. Dithiol-based compounds maintain expression of antioxidant protein peroxiredoxin 1 that counteracts toxicity of mutant huntingtin. J. Biol. Chem. 2012, 287:22717-22729.
28. Tsai H.F., Tsai H.J., Hsieh M. Full-length expanded ataxin-3 enhances mitochondrial-mediated cell death and creases Bcl-2 expression in human neuroblastoma cells. Biochem. Biophys. Res. Commun. 2004, 324:1274-1282.
29. Schraufstatter I.U., Hinshaw D.B., Hyslop P.A., Spragg R.G., Cochrane C.G. Oxidant injury of cells. DNA strand-breaks activate polyadenosine diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine dinucleotide. J. Clin. Invest. 1986, 77:1312-1320.
30. Reina C.P., Zhong X., Pittman R.N. Proteotoxic stress increases nuclear localization of ataxin-3. Hum. Mol. Genet. 2010, 15:235-249.
31. 2-induced oxidative stress by enhancing the interaction between Bcl-XL and Bax. Neuroscience 2013, 243:14-21.
32. Paulson H. Machado-Joseph disease/spinocerebellar ataxia type 3. Handb. Clin. Neurol. 2012, 103:437-449.
33. Saute J.A., Silva A.C., Souza G.N., Russo A.D., Donis K.C., Vedolin L., Saraiva-Pereira M.L., Portela L.V., Jardim L.B. Body mass index is inversely correlated with the expanded CAG repeat length in SCA3/MJD patients. Cerebellum 2012, 11:771-774.